Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)

PURPOSE: Formulation V (VONCENTO(®)) is a plasma-derived high-concentration/low-volume, high-purity von Willebrand factor (VWF)/factor VIII (FVIII) concentrate, originally indicated for von Willebrand disease (VWD) in adults and adolescents. This multicenter, open-label study (SWIFTLY-VWD) evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Auerswald, Guenter, Djambas Khayat, Claudia, Stasyshyn, Oleksandra, Iosava, Genadi, Romashevskaya, Irina, López, Marta Julia, Seifert, Wilfried, Rogosch, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319533/
https://www.ncbi.nlm.nih.gov/pubmed/32607039
http://dx.doi.org/10.2147/JBM.S236789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319533/
https://www.ncbi.nlm.nih.gov/pubmed/32607039
http://dx.doi.org/10.2147/JBM.S236789

Ejemplares similares